DISALCID
Dead / Abandoned — Abandoned — no statement of use filed (as of 05 Oct 2026)
What this means for you
This application is over — abandoned 05 Oct 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97370152
- Mark type
- Word mark
- Filed
- 19 Apr 2022
- Published for opposition
- 14 Mar 2023
- Abandoned
- 05 Oct 2026
- Attorney of record
- Stephen A. Seach, Jr.
Goods and services
- Class 005 — Pharmaceuticals: anti-inflammatory analgesic pharmaceutical preparation
Owner
- Oliva Therapeutics, LLC, Ridgewood, NJ, US
- Oliva Therapeutics, LLC, Ridgewood, NJ, US
Board proceedings on this mark
- Extension of Time to Oppose No. 97370152 — Merck Sharp & Dohme LLC v. Oliva Therapeutics, LLC, filed 12 Apr 2023 (Terminated)
Prosecution history
- 05 Oct 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 05 Oct 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2026 — SOU EXTENSION 5 GRANTED
- 11 Feb 2026 — SOU EXTENSION 5 FILED
- 24 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2025 — SOU EXTENSION 4 GRANTED
- 04 Sept 2025 — SOU EXTENSION 4 FILED
- 04 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Feb 2025 — SOU EXTENSION 3 GRANTED
- 16 Feb 2025 — SOU EXTENSION 3 FILED
- 16 Feb 2025 — SOU TEAS EXTENSION RECEIVED